Latest Ratios: P/E Ratio 34.6x · EV/EBITDA 22.3x · ROE 38.9%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $18.3B | $29.1B | $22.4B | $21.4B | $18.0B | $16.8B | $19.2B | $10.9B | $11.8B | $10.1B | $7.4B |
| Enterprise Value | $19.2B | $30.0B | $23.2B | $22.1B | $18.4B | $17.1B | $19.5B | $11.3B | $11.7B | $10.0B | $7.2B |
| P/E Ratio → | 34.55 | 55.06 | 48.28 | 49.07 | 48.72 | 47.51 | 72.35 | 53.93 | 51.21 | 57.44 | 44.15 |
| P/S Ratio | 4.58 | 7.73 | 6.62 | 6.96 | 6.67 | 6.94 | 8.89 | 5.39 | 6.49 | 6.06 | 4.68 |
| P/B Ratio | 13.37 | 21.14 | 16.87 | 18.52 | 14.20 | 15.15 | 20.40 | 13.31 | 16.60 | 15.51 | 12.96 |
| P/FCF | 27.18 | 44.70 | 38.70 | 43.16 | 41.33 | 44.94 | 46.56 | 38.51 | 45.61 | 48.14 | 38.10 |
| P/OCF | 26.93 | 42.85 | 36.94 | 40.51 | 38.62 | 41.89 | 44.07 | 35.13 | 41.28 | 43.09 | 32.54 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 7.98 | 6.84 | 7.20 | 6.84 | 7.07 | 9.03 | 5.59 | 6.42 | 6.00 | 4.59 |
| EV / EBITDA | 22.28 | 35.26 | 30.07 | 32.38 | 31.52 | 32.07 | 42.87 | 28.26 | 26.53 | 24.71 | 20.05 |
| EV / EBIT | 26.44 | 41.13 | 35.22 | 37.59 | 36.75 | 35.44 | 51.92 | 35.48 | 37.79 | 34.14 | 27.83 |
| EV / FCF | — | 46.15 | 39.94 | 44.60 | 42.34 | 45.73 | 47.33 | 39.92 | 45.16 | 47.63 | 37.36 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 52.8% | 52.8% | 52.7% | 52.2% | 51.5% | 52.0% | 51.5% | 50.7% | 50.9% | 51.0% | 50.9% |
| Operating Margin | 19.3% | 19.3% | 19.4% | 19.0% | 18.3% | 18.5% | 17.4% | 15.7% | 20.7% | 20.9% | 19.7% |
| Net Profit Margin | 14.0% | 14.0% | 13.8% | 14.2% | 13.7% | 14.7% | 12.3% | 10.1% | 12.7% | 10.7% | 10.6% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 38.9% | 38.9% | 37.5% | 35.9% | 31.0% | 34.7% | 30.4% | 26.6% | 33.9% | 29.3% | 30.6% |
| ROA | 17.7% | 17.7% | 17.2% | 18.4% | 17.8% | 18.4% | 14.9% | 14.4% | 21.8% | 18.4% | 18.9% |
| ROIC | 24.9% | 24.9% | 25.1% | 24.5% | 23.8% | 25.2% | 22.8% | 26.3% | 49.4% | 54.1% | 57.2% |
| ROCE | 32.1% | 32.1% | 31.3% | 32.0% | 31.2% | 30.8% | 27.8% | 29.9% | 49.1% | 50.9% | 50.1% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.76 | 0.76 | 0.61 | 0.71 | 0.42 | 0.36 | 0.44 | 0.60 | — | — | — |
| Debt / EBITDA | 1.22 | 1.22 | 1.05 | 1.20 | 0.91 | 0.75 | 0.92 | 1.24 | — | — | — |
| Net Debt / Equity | — | 0.68 | 0.54 | 0.62 | 0.35 | 0.27 | 0.34 | 0.49 | -0.16 | -0.16 | -0.25 |
| Net Debt / EBITDA | 1.10 | 1.10 | 0.94 | 1.04 | 0.75 | 0.56 | 0.70 | 1.00 | -0.26 | -0.26 | -0.40 |
| Debt / FCF | — | 1.44 | 1.25 | 1.44 | 1.01 | 0.79 | 0.77 | 1.41 | -0.45 | -0.51 | -0.74 |
| Interest Coverage | 25.54 | 25.54 | 23.77 | 30.88 | 190.13 | 582.31 | 85.83 | 47.97 | — | — | — |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.60 | 0.60 | 0.69 | 0.71 | 0.71 | 0.72 | 0.66 | 0.76 | 0.96 | 0.89 | 1.05 |
| Quick Ratio | 0.55 | 0.55 | 0.62 | 0.65 | 0.65 | 0.66 | 0.60 | 0.71 | 0.90 | 0.84 | 1.00 |
| Cash Ratio | 0.13 | 0.13 | 0.14 | 0.18 | 0.19 | 0.24 | 0.21 | 0.23 | 0.39 | 0.36 | 0.52 |
| Asset Turnover | — | 1.20 | 1.20 | 1.18 | 1.27 | 1.20 | 1.17 | 1.16 | 1.66 | 1.62 | 1.72 |
| Inventory Turnover | 41.34 | 41.34 | 40.56 | 44.03 | 43.99 | 40.19 | 34.00 | 51.02 | 56.65 | 54.72 | 56.28 |
| Days Sales Outstanding | — | 23.99 | 25.46 | 25.56 | 25.64 | 24.95 | 25.34 | 26.27 | 24.54 | 25.09 | 24.23 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 1.8% | 1.1% | 1.3% | 1.2% | 1.2% | 1.0% | 0.8% | 1.4% | 1.3% | 1.2% | 1.5% |
| Payout Ratio | 62.3% | 62.3% | 63.9% | 60.8% | 57.4% | 47.4% | 60.2% | 75.7% | 65.9% | 68.1% | 65.1% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 2.9% | 1.8% | 2.1% | 2.0% | 2.1% | 2.1% | 1.4% | 1.9% | 2.0% | 1.7% | 2.3% |
| FCF Yield | 3.7% | 2.2% | 2.6% | 2.3% | 2.4% | 2.2% | 2.1% | 2.6% | 2.2% | 2.1% | 2.6% |
| Buyback Yield | 1.2% | 0.7% | 0.1% | 1.5% | 0.0% | 0.1% | 0.0% | 0.1% | 0.1% | 0.1% | 0.4% |
| Total Shareholder Yield | 3.0% | 1.9% | 1.4% | 2.7% | 1.2% | 1.1% | 0.9% | 1.5% | 1.4% | 1.3% | 1.9% |
| Shares Outstanding | — | $484M | $484M | $490M | $492M | $492M | $492M | $491M | $491M | $490M | $491M |
Includes 30+ ratios · 30 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ROL stock.
Rollins, Inc.'s current P/E ratio is 34.6x. The historical average is 41.0x. This places it at the 41th percentile of its historical range.
Rollins, Inc.'s current EV/EBITDA is 22.3x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 20.3x.
Rollins, Inc.'s return on equity (ROE) is 38.9%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 27.6%.
Based on historical data, Rollins, Inc. is trading at a P/E of 34.6x. This is at the 41th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Rollins, Inc.'s current dividend yield is 1.78% with a payout ratio of 62.3%.
Rollins, Inc. has 52.8% gross margin and 19.3% operating margin. Operating margin between 10-20% is typical for established companies.
Rollins, Inc.'s Debt/EBITDA ratio is 1.2x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.
Key Metrics
Top Statement Risk
Premium valuation unsupported by return profile
Metrics are mathematically derived from official filings.
Premium Multiple Absorbing Growth Decay
Rollins trades at 31.95x trailing earnings and 20.71x EV/EBITDA, a premium to deathcare and facility services peers generating materially higher returns; per recent market data, this multiple appears to price continued double-digit EPS compounding even as quarterly growth has decelerated to 6.2%.
The 31.95x trailing P/E and 2.12 PEG imply the market is paying for mid-teens earnings growth, yet the forward P/E of 30.31 offers only a modest discount, suggesting limited room for earnings to grow into the multiple. Compared with Service Corporation at 21.92x and ABM at 20.72x, the premium appears difficult to justify on return metrics alone, given ROIC of 6.9% versus SCI's 11.3% and ABM's 7.5%. Cintas at 45.64x and 26.7% ROIC looks like the only peer whose multiple is arguably earned, and investors should monitor whether ROL's valuation gap versus Rentokil narrows as consolidation proceeds.
Returns Drift Below Acquisition Cost of Capital Assumptions
ROIC of 6.9% in 2026Q3 sits below the 7.1% printed in 2024Q3 and far beneath Cintas' 26.7%, according to Rollins' quarterly ratio disclosures, implying the acquisition-led additions have not yet lifted returns on the expanding capital base.
ROIC has oscillated in a 4.7%–7.3% band across ten quarters with no discernible upward trend, while ROA has held near 4.4–5.1%, which suggests recent growth is more a function of added balance sheet than of improved unit economics. The spread between ROE of 11.2% and ROIC of 6.9% reflects leverage and an equity base thinned by $1.5B of goodwill, so ROE likely overstates the return generated on genuinely productive capital. If acquisition multiples of 1–2x revenue continue to be paid against a ~6.9% return profile, investors should question whether the roll-up is still creating spread over its cost of capital.
Payables Stretching Masks Asset Turnover Slippage
The cash conversion cycle tightened to 19 days in 2026Q3 from 25 in 2025Q4, driven mainly by payables stretching to 14 days from 10, as Rollins' reported working capital data shows; asset turnover, however, has slipped to 0.32 from 0.33.
The CCC improvement appears to be sourced on the supplier side rather than from faster collections, with DSO essentially flat near 23–28 days across the window, which may indicate terms are being lengthened to preserve cash rather than that customer payment behavior improved. Combined with asset turnover holding at a structurally low 0.29–0.33, the business converts a large and growing asset base into modest revenue per dollar, a signature of an acquisition-heavy services platform rather than a productivity breakout. A reversal in payables terms would hand back the entire CCC gain, so this efficiency looks more fragile than the headline 19-day figure implies.
Leverage Creep Absorbed by Comfortable Coverage
Debt has risen roughly 26% since 2024Q2 to $1.1B, lifting debt-to-equity to 0.81 while interest coverage eased to 20.93x from 23.51x, based on Rollins' balance sheet history; servicing remains comfortable even as borrowing has outpaced equity retention.
Debt-to-EBITDA of 4.40x is above the 3.55x seen in 2025Q3, confirming that leverage is drifting higher as acquisitions are debt-funded, though coverage above 20x still leaves a wide cushion for rate or margin shocks. Because equity was roughly flat at $1.4B while total assets grew to $3.4B, the headline 0.81 D/E ratio may understate true fragility; on a tangible basis, with goodwill at $1.5B exceeding equity, net leverage against tangible capital is materially higher than reported. Refinancing risk appears low today, but investors should monitor whether incremental debt continues to fund growth that does not yet show up in ROIC.
Thin Buffer Presumes Uninterrupted Conversion
A current ratio of 0.62 and quick ratio of 0.58 in 2026Q3 leave limited on-hand slack against $2.0B of total liabilities, as reported in Rollins' latest quarterly filings, a posture that presumes uninterrupted operating cash conversion rather than a cash buffer.
The ratios have drifted lower from 0.78 and 0.72 in 2024Q2, and with cash of only $129.1M, the model leans on recurring monthly collections and deferred termite receipts to fund near-term obligations; the quick ratio tracking within 0.04 of the current ratio confirms there is little inventory dependence to cushion a shortfall. Under a scenario where consumer-initiated lead volumes keep weakening and termite bookings slip further, as evidenced by deferred revenue drifting down about 4% year-over-year, the working capital inflow that supports this liquidity posture could slow. The structure is defensible given FCF margins of 21.6%, but it is not self-insuring and warrants monitoring of quarterly operating cash generation.
ROE Is the Wrong Lens Here
The 11.2% ROE most often cited is arguably the wrong lens, since goodwill of $1.5B exceeds the $1.4B equity base; based on Rollins' balance sheet, returns measured on tangible capital are effectively unmeasurable, making ROIC or ROFO the more honest measure.
For a roll-up business where nearly 44% of assets are acquisition-generated intangibles, ROE flatters performance because the denominator is small and stripped of the very capital that was deployed to buy growth; a single impairment would mechanically shrink equity and inflate ROE further, the opposite of what a deteriorating franchise should signal. Analysts should instead anchor on ROIC of ~6.9% or, better, returns on field operating assets, since net property and equipment of $505.3M is the true productive base. Reading ROL's compounding story through P/E alongside a normalized ROIC, rather than ROE, appears to better separate genuine route-density economics from balance-sheet arithmetic.